Sleep Awareness Week® Sponsor Blog - National Sleep Foundation

Sleep Awareness Week^® Sponsor Blog

Hear from NSF’s 2023 Sleep Awareness Week^® Sponsors

This year, as part of Sleep Awareness Week^®, NSF welcomes the contributions and perspectives of our sponsors. Read more to learn about their work.

At Primasun, we believe sleep is the foundation of health. It restores our bodies, energizes our days, and enriches our communities. When we sleep well, we can rediscover the world through rested eyes and achieve a better quality of life.

Primasun is Working to Make Sleep the Medicine Everyone Can Access

At Harmony Biosciences, we specialize in developing and delivering treatments for rare neurological diseases that others often overlook. We believe that where empathy and innovation meet, a better life can begin for people living with neurological diseases.

Harmony Biosciences’ Commitment to Rare Neurological Disease and Sleep Disorder Communities

In today's fast-paced world, some people often prioritize work over sleep, sacrificing our well-being in the process. Some of us stay up late, work long hours, and expose ourselves to artificial light at night, disrupting our circadian rhythm.

How AYO is Supporting Circadian Health and Sleep

NLS Pharmaceutics is a global development-stage biopharmaceutical company, working with a network of world-class partners and internationally recognized scientists, focused on the discovery and development of innovative therapies for patients with rare and complex central nervous system, or CNS, disorders, who have unmet medical needs, such as narcolepsy and idiopathic hypersomnia.

NLS Pharmaceutics: Innovating the Future of Narcolepsy Treatment

Idorsia is a biotech start-up like no other, founded in 2017 by a husband-and-wife physician team, Jean-Paul and Martine Clozel. Idorsia set its sights on one of the most prevalent sleep disorders, insomnia, estimated to impact 25 million US adults [1],[2], because Idorsia saw insomnia and its consequences were not prioritized by the general public or medical community.

Idorsia Pharmaceuticals: The Night & Day Impact of Insomnia

At Apnimed, we are working to transform the treatment of obstructive sleep apnea (OSA) based on a simple idea – people with OSA could benefit from treatment with an oral medication. We are at the clinical trial stage of developing oral medications that address the disorder’s underlying neurobiology to activate upper airway muscles and maintain an open airway during sleep.

New Approaches in the Treatment of Obstructive Sleep Apnea

As a long-time leader in sleep medicine, Jazz has been at the forefront of providing therapies and support for people living with serious, debilitating neurologic disorders. People with sleep disorders live with complex and severe conditions, which few understand. We are committed to ongoing innovation with their needs in mind, and we are proud to support National Sleep Foundation’s 25th Annual Sleep Awareness Week.

Understanding Heart Health in Narcolepsy